Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism treatment should focus more on patient needs and quality of life.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Blood vessels and specific genes help turn cartilage into bone when bones heal.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Too much androgen can cause hair loss; finasteride may help.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Finasteride improves hair loss in women with hyperandrogenism.

Minoxidil and finasteride effectively treat hair loss.